All blog posts
Total 8 results for
Showing 8 out of 8 results
21 11月 2022
Emma And Rebekah Talk IP: COVID-19 vaccines and IP – dissecting the flurry of recent patent lawsuits
06 5月 2020
Update on medicines and medical devices regulation in the EU and the UK and the impact of COVID-19
30 4月 2020
COVID-19: Pressure Points: Supply Chain Difficulties – new global guide, including IP, advertising and collaboration issues
08 4月 2020
COVID-19: PRESSURE POINTS: Order SND/326/2020, of 6 April, which establishes special measures to grant prior operating permits for facilities and to use certain medical devices lacking CE certification as a result of the medical crisis linked to the COVID-19 outbreak (Spain)
08 4月 2020
COVID-19: Pressure Points: A Catalyst for Collaboration (Global)
03 4月 2020
COVID-19: Potential legal impact (latest developments) - Pharma (Spain) (03/04/2020)
19 3月 2020
COVID-19: Potential legal impact (latest developments) – Pharma (Spain)
16 3月 2020
COVID-19: Potential legal impact - Pharma (Spain)
Showing 8 out of 8 results
Key contacts
Rebekah Gay
Partner, Head of Intellectual Property, Sydney
Laura Orlando
Managing Partner, Milan Office, Milan
Sue Gilchrist
Consultant, Sydney
雷鹏
科伟史密夫斐尔凯迈联营办公室合伙人, Mainland China and Shanghai
Alexandra Neri
Partner, Paris
Dr Ina vom Feld
Partner, Germany
Sebastian Moore
Partner, Head Intellectual Property, London and Milan
Rachel Montagnon
Knowledge Counsel, London